Bonnie L. Bassler - Feb 3, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Stock symbol
REGN
Transactions as of
Feb 3, 2023
Transactions value $
-$406,409
Form type
4
Date filed
2/7/2023, 03:09 PM
Previous filing
Jan 5, 2023
Next filing
Mar 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $389K +1.02K +81.88% $380.95 2.27K Feb 3, 2023 Direct F1
transaction REGN Common Stock Sale -$795K -1.02K -45.02% $779.00 1.25K Feb 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.02K -21.54% $0.00 3.72K Feb 3, 2023 Common Stock 1.02K $380.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.